No Data
This Primoris Services Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Needham Initiates Coverage On Ocular Therapeutix With Buy Rating, Announces Price Target of $15
Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Express News | Citizens Capital Markets Maintains Market Outperform on Ocular Therapeutix, Lowers Price Target to $19
Scotiabank Maintains Ocular Therapeutix(OCUL.US) With Buy Rating, Maintains Target Price $22
A Quick Look at Today's Ratings for Ocular Therapeutix(OCUL.US), With a Forecast Between $15 to $22
70581059 : a great buying opportunity in general. if the tariff stays, it has already been priced in. in case not, it will surge back.